01 4Diflucan
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2019 Revenue in Millions : 190
2018 Revenue in Millions : 189
Growth (%) : 1
Main Therapeutic Indication : Anti-fungal
Currency : USD
2014 Revenue in Millions : -9.10%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Anti-fungal
Currency : USD
2015 Revenue in Millions : 208
2014 Revenue in Millions : 181
Growth (%) : -13%
Main Therapeutic Indication : Anti-Fungal
Currency : USD
2016 Revenue in Millions : 119
2015 Revenue in Millions : 181
Growth (%) : -34
LOOKING FOR A SUPPLIER?